Navigation Links
JDRF Partner ViaCyte Announces Key Project Milestone to Advance Innovative Encapsulated Cell Replacement Therapy Product for Type 1 Diabetes
Date:7/17/2014

by hiding them from the immune system, providing a safe environment where they can function normally. The cells can constantly assess the amount of glucose in the blood and release exactly the correct amount of insulin. Importantly, encapsulation therapy overcomes one of the major obstacles that has slowed progress in the islet transplant field, which is the need for lifetime administration of powerful and toxic immunosuppressive drugs to prevent the immune system from destroying the newly introduced islets.

ViaCyte's VC-01 product candidate, a cell replacement therapy could potentially transform the way individuals with T1D manage their disease by supplying an alternative source of insulin-producing cells with the potential to free individuals from a dependence on external insulin use.  If the product candidate performs as intended, it has the potential to provide individuals who have T1D with a replacement for the beta cells lost or impaired as a result of their disease.

Beta cell encapsulation research is a high priority research area for JDRF because of its potential benefits for individuals with T1D. JDRF has provided substantial funding for multiple scientific research programs to advance discovery and development research in this area.  

About JDRF
JDRF is the leading global organization funding type 1 diabetes (T1D) research.  JDRF's goal is to progressively remove the impact of T1D from people's lives until we achieve a world without T1D.  JDRF collaborates with a wide spectrum of partners and is the only organization with the scientific resources, regulatory influence, and a working plan to better treat, prevent, and eventually cure T1D.  As the largest charitable supporter of T1D research, JDRF is currently sponsoring $568 million in scientific research in 17 countries. For more information, please visit jdrf.org.

Media Contact:

SOURCE JDRF
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
2. Fuse Science Partners With GNC To Open National Distribution Of EnerJel™
3. Medical Guardian Announces Social Media Partnership with Senior Citizen Charity
4. Synteract and Rempex Partner in "Great Strides" Walk to Support Cystic Fibrosis Cure
5. The ALS Therapy Development Institute Partners with Neurotune to Investigate Potential Treatments for Motor Neuron Disease
6. Cardium to Present at Sachs Associates 2012 Science, Partner, and Investment Forum: Gateway for the Global Life Sciences
7. Bilcare and CSIR to Partner on nonClonableID Technology for Authentication of Drugs
8. ClearCanvas Partners With DPR to Offer CaseReader™, an Integrated Technology Structured Reporting Solution for Medical Imaging Professionals
9. VitaTech Adds New Capacity for Production and Customer Interface, Attributes Growth to Strategic Customer Partnerships
10. PharmaNet/i3 Receives Distinguished Partner Award from the US Chinese Anti-Cancer Association
11. Bayer Partnership Delivers Industry-First Dose Management Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... LONDRES, 28 de agosto de 2015   ... su participación en el  Congreso de la ESC ... más recientes y novedosas, entre ellas HeartModel A.I. ... las personas y la tecnología con los protocolos ... guiar los tratamientos y permitir atención en el ...
(Date:8/27/2015)... 27, 2015  The Academy of Managed Care ... Administration,s (FDA,s) draft guidance and proposed rule that ... to bear a nonproprietary name with an FDA-designated ... a decision from the FDA on the naming ... stakeholders urging the agency to use the same ...
(Date:8/27/2015)... , Aug. 27, 2015 Biosimilars ... (BPC) applauds the U.S. Food and Drug Administration ... distinguishable name in its draft guidance issued today. ... biological products proposes distinguishable names, calling for biological ... an FDA-designated suffix. This proposal reflects the agency,s ...
Breaking Medicine Technology:Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5AMCP Is Disappointed in FDA's Draft Guidance and Proposed Rule Calling for Suffix on Nonproprietary Names of Biological Products 2Biologics Prescribers Collaborative (BPC) Statement on FDA Draft Guidance entitled "Nonproprietary Naming of Biological Products" 2
... CHARENTON-LE-PONT, France , July 13, 2010 ... its,commitment not to create any dilution for existing shareholders. The two-part,transaction was ... were cancelled to offset the dilutive impact of the, ... granted, to employees., - ...
... NEW YORK , July 12 DrChrono.com , the premier ... world-renowned iPad EMR app , featuring the ability to build macros and customizable ... DrChrono.com and its iPad EMR ... Wall Street Journal , Newsday , The Health ...
Cached Medicine Technology:Essilor Cancels Four Million Shares 2DrChrono.com iPad EMR Introduces Macros, Customizable SOAP Notes 2DrChrono.com iPad EMR Introduces Macros, Customizable SOAP Notes 3DrChrono.com iPad EMR Introduces Macros, Customizable SOAP Notes 4
(Date:8/28/2015)... ... ... Rio Salado College joined nine educational institutions in Washington D.C., July ... - Next Generation Learning Challenges 2015 Breakthrough Models Incubator funded by the Bill ... hosted by EDUCAUSE and NGLC, which is designed to bring leadership teams of ...
(Date:8/28/2015)... ... August 28, 2015 , ... Approximately 2,000 United Methodists ... celebrate children helping children, a thank you to the many creative and generous ... to the United Methodist initiative to end malaria deaths. , The Columbus Zoo ...
(Date:8/28/2015)... ... , ... With the goal of furthering music education programs in schools, the ... County Fairgrounds in Mendon, IL on May 30th, 2015. Backed once again by Best ... the underfunded school districts of Mendon and its neighboring town of Quincy, IL. Best ...
(Date:8/28/2015)... , ... August 28, 2015 , ... As reported ... Merz, received FDA clearance for results that last for two years, the longest ... news for patients who are looking for a long-lasting, effective solution for their cellulite, ...
(Date:8/28/2015)... Michigan (PRWEB) , ... August 28, 2015 , ... ... alcohol abuse, or those who might personally be struggling with chemical dependency, may ... post from Best Drug Rehabilitation, a results-driven holistic treatment center for addiction located ...
Breaking Medicine News(10 mins):Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 2Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 3Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 4Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 3Health News:Best Drug Rehabilitation Interviews Country-Rock Duo Highway Run at the 2015 "Music With A Mission" Benefit Concert 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 2Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 3
... Harbor Laboratory (CSHL) has demonstrated for the first time ... can initiate signaling that regulates both the structure and ... suggests a significant role for this class of receptors ... but also in cognition and in pathological processes in ...
... strike small percentage of patients , , WEDNESDAY, June 18 ... new side effect associated with the cancer drug Gleevec ... leukemia and gastrointestinal stromal tumors. , In a letter ... New England Journal of Medicine , the doctors describe ...
... Controlling heart rate is key when heart failure, irregular ... News) -- When added to heart failure, the irregular ... , Now, an international study shows that a ... best first option for keeping patients healthy under these ...
... HILL, N.C., June 18 A CI head once ... have it, but the only,time you realize you need ... In today,s marketing space, most companies need competitive,intelligence to ... the key insights are lacking that people begin to ...
... Prevent Skin Cancer, HOUSTON, June 18 Now that ... us, the cancer care experts at Texas Oncology remind,Texans to ... Although the most prevalent cancer in the United States today,skin ... more than 1,million annual U.S. cases of skin cancer are ...
... List from a ... Worldwide Field of 5,000, PHILADELPHIA, June ... of SCA Personal Care, from among,5,000 companies for inclusion in its ... think-tank dedicated to the research and,promotion of profitable best practices in ...
Cached Medicine News:Health News:Neuroscientists show insulin receptor signaling regulates structure of brain circuits 2Health News:Neuroscientists show insulin receptor signaling regulates structure of brain circuits 3Health News:Cancer Drug Gleevec Linked to Muscle Damage 2Health News:Cardiologists Spot Best Treatment for a Deadly Duo 2Health News:Cardiologists Spot Best Treatment for a Deadly Duo 3Health News:Build and Maintain an Effective Competitive Intelligence Group 2Health News:Texas Oncology Urges Texans to 'Save Your Skin' 2Health News:Texas Oncology Urges Texans to 'Save Your Skin' 3Health News:Ethisphere Institute Names SCA to List of Top Ethical Companies 2
... new Finnpipette Focus from Thermo ... combine ergonomics with uncompromising performance. ... plate offers a custom fit ... new shorter tip cones allow ...
... Finnpipette Focus from Thermo Labsystems ... ergonomics with uncompromising performance. ... offers a custom fit for ... shorter tip cones allow easier ...
... is ideal for repeated pipetting ... volume FInnpipettes offer the same ... Finnpipette Digital pipettes: New, ... Soft-touch tip ejection, Safety label, ...
... Focus from Thermo Labsystems was ... with uncompromising performance. The ... a custom fit for different ... tip cones allow easier and ...
Medicine Products: